Epitomee Medical Ltd Financial Flexibility Index

Latest as of June 2025: -1.78x

Epitomee Medical Ltd financial flexibility index. Epitomee Medical Ltd (EPIT) has a Financial Flexibility Index of -1.78x as of June 2025. Free cash flow of ILA-11.23 Million (operating CF ILA-12.78 Million minus capex ILA1.56 Million) represents -2% of total liabilities (ILA6.32 Million). Explore EPIT capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Financial Flexibility Index

-1.78x
Free Cash Flow / Total Liabilities

Free Cash Flow

ILA-11.23 Million
Operating CF − Capex

Total Liabilities

ILA6.32 Million
ILA

Capital Expenditures

ILA1.56 Million
ILA

Financial Flexibility Index of Epitomee Medical Ltd (2019–2024)

Financial flexibility index of Epitomee Medical Ltd from 2019 to 2024. Historical Financial Flexibility Index trend for Epitomee Medical Ltd across 6 annual periods. Check Epitomee Medical Ltd (EPIT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Epitomee Medical Ltd Financial Flexibility Index by Year (2019–2024)

Epitomee Medical Ltd financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Epitomee Medical Ltd. For the full cash flow conversion analysis, see EPIT cash flow conversion.

Year Flexibility Index Free Cash Flow (ILA) Operating CF Total Liabilities YoY Change
2024 -0.59x ILA-3.68 Million ILA-8.29 Million ILA6.26 Million ▲ +16.6%
2023 -0.70x ILA-3.85 Million ILA-7.92 Million ILA5.46 Million ▼ -93.9%
2022 -0.36x ILA-5.72 Million ILA-9.42 Million ILA15.76 Million ▲ +13.7%
2021 -0.42x ILA-5.36 Million ILA-5.76 Million ILA12.73 Million ▼ -206.5%
2020 0.40x ILA6.85 Million ILA6.75 Million ILA17.34 Million ▲ +111.8%
2019 -3.36x ILA-2.67 Million ILA-2.79 Million ILA794.00K —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities